Navigation Links
WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
Date:10/14/2008

SHANGHAI, China, Oct. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced preliminary selected unaudited financial results for the third quarter ended September 30, 2008, and updated its guidance for the full year 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Third Quarter 2008 Preliminary Unaudited Financial Results

For the third quarter ended September 30, 2008, WuXi reports the following preliminary unaudited financial results. These results are subject to change as a result of finalization of share-based compensation expenses, closing adjustments and completion of the review process for the quarter.

Preliminary Third Quarter 2008 Financial Results

(Unaudited, U.S. Dollars in Millions)

GAAP Non-GAAP

The third quarter of The third quarter of

2008 2007 % 2008 2007 %

Growth* Growth*

Net Revenue $66.0 - 67.5 $34.0 96% $66.0 - 67.5 $34.0 96%

Laboratory

Services 46.0 - 47.0 26.7 74% 46.0 - 47.0 26.7 74%

Manufacturing

Services 20.0 - 20.5 7.3 177% 20.0 - 20.5 7.3 177%

Gross Profit 21.4 - 22.9 16.0 38% 25.9 - 27.4 16.3 63%

Laboratory

Services 18.7
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors
2. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
3. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
4. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
5. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
6. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
7. WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
8. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
9. WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
10. Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal
11. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... DuPont Knowledge Center is First Integrated Kno... Hyderabad, India (Vocus) Novembe...edge Center (DKC) today, 17 months after breaking ...ICI Knowledge Park in the city’s Genome Vall...d the Asia Pacific region in the areas of agricult...
(Date:11/21/2008)...INANCIAL AND RESTRUCTURING ALTERNATIVES ONGOING ,... - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI...d medical device company, today announced that the...s) and New Leaf Venture Partners (New Leaf) that t...eement dated July 7, 2008. Angiotech had announced...
(Date:11/21/2008)...Newswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq:, ...tion services under the,LasikPlus(R) brand, today...e,to the position of Chief Financial Officer on a.... Celebrezze, who has served as interim CFO since ...ive Management team as Senior Vice,President of F...
(Date:11/20/2008)...lfast is to become the United Kingdom,s lead centr...us ,cyber-attacks, after a funding boost from the .... , Almost 7m from the EPSRC will help fund a n...r Secure Information Technologies (CSIT) - which w...Communications and Information Technology (ECIT) i...
Breaking Biology Technology:DuPont Opens Research & Development Center in India 2DuPont Opens Research & Development Center in India 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4LCA-Vision Names Michael J. Celebrezze CFO 2LCA-Vision Names Michael J. Celebrezze CFO 3LCA-Vision Names Michael J. Celebrezze CFO 4Queen's 'secures' £25m for UK's cyber-safety 2
... pooled to place ads on their round, shiny stomach...s is how news is created. To some, this is "desper...d-to-fail branding," a process that ensures a top ...cts are sometimes called "reality branding." There...ey said, "You need branding when your product has ...
...thcare reported Monday that it has signed a multi...ealth System to develop new, minimally invasive s...ors will use GE Healthcare,s surgical navigation t... research less invasive methods of therapeutic and...,"This research agreement is the beginning of an i...
... uses Medical College of Wisconsin technologies an...awarded $2.5 million for development of diagnostic...en, Inc., said the research grant, which will com...elop improved molecular biological methods, miniat...ce of this new molecular diagnostic approach to di...
...tware , a provider of automated document delivery ...pening of a new mail house at its U.S. headquarter...f the Esker on Demand service. , ,The new mail p...ed by the company,s existing facility in Lyon, Fra...Esker on Demand service, which also provides autom...
Other Biology Technology:A final word on branding 2A final word on branding 3A final word on branding 4A final word on branding 5
(Date:11/20/2008)... For millennia, people have grown soybeans and tu...omes to understanding why a soybean grows, blooms ...h unanswered questions. , University of Georgia...with a three-year, $2.5 million grant from the Nat...e found by a UGA colleague. , "I,m convinced tha...
(Date:11/19/2008)... Fighting virtual crime, treating an ageing popul...rises, will be the focus of a 20 million ($30.4 mi...ng and Physical Sciences Research Council (EPSRC),...logy and Biological Sciences Research Council (BBS...entres in areas where world-class scientific break...
(Date:11/19/2008)... LOS ANGELES -- The National Academy of Sciences (...and Entertainment Exchange," an initiative designe...with top scientists and engineers to help the crea...other productions incorporate science into their w...formal effort to reach out to the entertainment co...
(Date:11/19/2008)... Here is the latest American Chemical Society (AC..., 36 peer-reviewed journals and Chemical & Engine... or the American Chemical Society as the source fo...TE RELEASE EXCEPT ARTICLE #5, which is embargoed f..., , ARTICLE #1 FOR IMMEDIATE RELEASE , Microc...
Breaking Biology News(10 mins):Soybean grant gives researchers tools to unravel better bean 2£20 million to fight virtual crime and treat our ageing population 2£20 million to fight virtual crime and treat our ageing population 3NAS announces initiative to connect entertainment industry with top experts 2NAS announces initiative to connect entertainment industry with top experts 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 2American Chemical Society's Weekly PressPac -- Nov. 19, 2008 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 4American Chemical Society's Weekly PressPac -- Nov. 19, 2008 5American Chemical Society's Weekly PressPac -- Nov. 19, 2008 6American Chemical Society's Weekly PressPac -- Nov. 19, 2008 7American Chemical Society's Weekly PressPac -- Nov. 19, 2008 8Rh Apo2L Named as One of Chinas High Tech Transforming Products by Chinese Government 7579 1Rh Apo2L Named as One of Chinas High Tech Transforming Products by Chinese Government 7579 2Acura Pharmaceuticals Inc Announces Implementation of Reverse Stock Split and New Trading Symbol 3A ACPH 7574 1Acura Pharmaceuticals Inc Announces Implementation of Reverse Stock Split and New Trading Symbol 3A ACPH 7574 2Acura Pharmaceuticals Inc Announces Implementation of Reverse Stock Split and New Trading Symbol 3A ACPH 7574 3Acura Pharmaceuticals Inc Announces Implementation of Reverse Stock Split and New Trading Symbol 3A ACPH 7574 47 or 8 Hours of Sleep Best for Health 7569 1Worlds most powerful MRI ready to scan human brain 7566 1Worlds most powerful MRI ready to scan human brain 7566 2
...eived $2.4 million to study whether environmental ... system to cause additional damage in people with ...elieves long-term exposure to certain environmenta...n as NKG2D--in lung cells that causes the immune s..., "When tissue is exposed to a pathogen (disease-c...
...ists at Johns Hopkins have linked a gene that allo...tive casing that houses insects and worms to the s...ronic sinusitis. , A team of Hopkins sinus expe... mammalian chitinase (AMCase), is up to 250 times ...on that persists even after surgery when compared ...
...two bacterial muscle infections common in tropical...g with the emergence of community-acquired methici...cording to a study published in the Oct. 15 issue ...ine. , Staphylococcus aureus, or staph, is a commo...quarter to a third of all people. Usually harmless...
...t suppresses tumor cell growth also plays a key ro...entration, or expression, of the gene p16INK4a in ...red to young cells and remembered their "age" even... cells of mice bred without the gene showed less s...unction in a manner more similar to cells from you...
Other Biology News:Environmental toxins may cause body's defenses to worsen lung disease 2Environmental toxins may cause body's defenses to worsen lung disease 3Hopkins scientists link immune response to 'ghost' parasites and severely congested sinuses 2Hopkins scientists link immune response to 'ghost' parasites and severely congested sinuses 3Hopkins scientists link immune response to 'ghost' parasites and severely congested sinuses 4Study shows antibiotic-resistant bacteria responsible for increase in muscle infections 2Studies find general mechanism of cellular aging 2Studies find general mechanism of cellular aging 3
Rabbit polyclonal to JAK2 (phospho Y1007) ( Abpromise for all tested applications). Antigen: Synthesized phosphopeptide derived from human JAK2 around the phosphorylation site of tyrosine 1007 (
...r (IC) Fixation Buffer, used in conjunction with e...33), can be used to fix and permeabilize cells pri...es and other cytoplasmic and/or nuclear antigens. ... reducing non-specific staining by fluorochrome-la...
Harmful, Irritant, Combustible ,DEPC
Rabbit polyclonal to JMJD2D ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH derived from within residues 400 - 500 of Human JMJD2D.(Note: the amino acid se
Biology Products: